Polyclonal origin of colonic adenomas in an XO/XY patient with FAP

Science

Volumn 272, Issue 5265, 1996, Pages 1187-1190

  Novelli, M R ^a   Williamson, J A ^a   Tomlinson, I P M ^a   Elia, G ^a   Hodgson, S V ^a   Talbot, I C ^a   Bodmer, W F ^a   Wright, N A ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CASE REPORT; CHROMOSOME MOSAICISM; COLON ADENOMA; CONTROLLED STUDY; CRYPT CELL; FAMILIAL COLON POLYPOSIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KARYOTYPE 45,X; KARYOTYPE 46,XY; LARGE INTESTINE; MALE; MICROADENOMA; PRIORITY JOURNAL; SMALL INTESTINE;

EID: 0029938751     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.272.5265.1187     Document Type: Article

References (34)

1. B. A. J. Ponder et al., Nature 313, 689 (1985).
2. D. F. R. Griffiths, S. J. Davies, D. Williams, G. Williams, E. D. Williams, ibid. 333, 461 (1988).
3. D. J. Winton, M. A. Blount, B. A. J. Ponder, ibid., p. 463.
4. G. H. Schmidt, D. J. Winton, B. A. J. Ponder, Development 103, 785 (1988).
5. P. Armitage and R. Doll, Br. J. Cancer 8, 1 (1954).
6. A. G. Knudson, Adv. Cancer Res. 17, 317 (1973).
7. P. J. Fialkow, Annu. Rev. Med. 30, 135 (1979).
8. H. Rubin, Cancer Res. 45, 2935 (1985).
9. P. Alexander, Br. J .Cancer 51, 453 (1985).
10. E. M. Thompson et al., Development 110, 477 (1990).
11. The protein truncation test was used to search all regions of the patient's APC gene for germline mutations [R. van der Luijt et al., Genomics 20, 1 (1994)]. This assay provided evidence of a mutation in region G of APC exon 15. This region was specifically amplified from genomic DNA by polymerase chain reaction (PCR), and the PCR product was sequenced in forward and reverse orientation.
12. J. Ragoussis et al., Genomics 14, 673 (1992).
13. The reference for the cY97 probe is J. Wolfe et al., J. Mol. Biol 182, 477 (1985). The pDP105 probe was obtained from the American Type Culture Collection (Rockville, MD) [M. Andersson, D. C. Page, A. de la Chapelle, Science 233, 786 (1986)].
14. The reference for the cY97 probe is J. Wolfe et al., J. Mol. Biol 182, 477 (1985). The pDP105 probe was obtained from the American Type Culture Collection (Rockville, MD) [M. Andersson, D. C. Page, A. de la Chapelle, Science 233, 786 (1986)].
15. DMA probes were labeled with biotin-14-adenosine triphosphate (Boehringer Mannheim, Lewes, UK) with the use of a Bionick kit (Life Technologies, Paisley, UK). The DNA was purified by passage through a Sephadex G50 column and ethanol precipitation NISH was performed as previously described (H. M J. Kerstens, P. J. Poddighe, G. J. M. Hanselaar, Histochem. Cytochem. 42, 1971 (1994)]. Signal was detected immunohistochemically with (i) monoclonal mouse antibody to biotin (1:20) (Dakopatts, High Wycombe, UK), (ii) biotinylated rabbit immunoglobulins to mouse immunoglobulins (1:200) (Dakopatts), and (iii) streptavidin-HRP (1:400) (Dakopatts).
16. A. G. E. Pearse, in Endocrine Tumours: the Pathobiotogy of Regulatory Peptide-Producing Tumours, J. M. Polak and S. R. Bloom, Eds. (Churchill Livingstone, Edinburgh, UK, 1985), pp. 82-94.
17. C. E. Fuller, R. P. Davies, G. T. Williams, E. D. Williams, Br. J. Cancer 61, 382 (1990).
18. E. D. Williams, A. P. Lowes, D. Williams, G. T. Williams, Am. J. Pathol. 141, 773 (1992).
19. Dysplasia is defined as "cells having undergone proliferation and atypical cytological alterations involving cell size, shape, and organization" [R. S. Cotran, V. Kumar, S. L. Robbins, Robbins Pathological Basis of Disease (W. B. Saunders, Philadelphia, PA, 1989)].
20. E. Beutler, Z. Collins, L. E. Irwin, N. Engl. J. Med 276, 389 (1967).
21. S. H. Hsu, G. D. Luk, A. J. Krush, S. R. Hamilton, H. H. Hoover Jr., Science 221, 951 (1983).
22. E. R. Fearon, S. R. Hamilton, B. Vogelstein,ibid. 238, 193 (1987).
23. B. A. Ponder and M. M. Wilkinson, J. Natl. Cancer Inst. 77, 967 (1986).
24. D. Rau et al., Hum. Genet. 89, 64 (1992); S. Hunter, T. Gramlich, K. Abbott, V. Varma. Genes Chromosomes Cancer 8, 172 (1993); A. A. Sandberg, J. Cell Biochem. Suppl. 161, 76 (1992); J. J. Konig et al., Prostate 25, 281 (1994); P. H. Rao et al., Diagn. Mol. Pathol. 2, 264 (1993); G. Kovacs, K. Tory, A. Kovacs, J. Pathol. 173, 39 (1994).
25. D. Rau et al., Hum. Genet. 89, 64 (1992); S. Hunter, T. Gramlich, K. Abbott, V. Varma. Genes Chromosomes Cancer 8, 172 (1993); A. A. Sandberg, J. Cell Biochem. Suppl. 161, 76 (1992); J. J. Konig et al., Prostate 25, 281 (1994); P. H. Rao et al., Diagn. Mol. Pathol. 2, 264 (1993); G. Kovacs, K. Tory, A. Kovacs, J. Pathol. 173, 39 (1994).
26. D. Rau et al., Hum. Genet. 89, 64 (1992); S. Hunter, T. Gramlich, K. Abbott, V. Varma. Genes Chromosomes Cancer 8, 172 (1993); A. A. Sandberg, J. Cell Biochem. Suppl. 161, 76 (1992); J. J. Konig et al., Prostate 25, 281 (1994); P. H. Rao et al., Diagn. Mol. Pathol. 2, 264 (1993); G. Kovacs, K. Tory, A. Kovacs, J. Pathol. 173, 39 (1994).
27. D. Rau et al., Hum. Genet. 89, 64 (1992); S. Hunter, T. Gramlich, K. Abbott, V. Varma. Genes Chromosomes Cancer 8, 172 (1993); A. A. Sandberg, J. Cell Biochem. Suppl. 161, 76 (1992); J. J. Konig et al., Prostate 25, 281 (1994); P. H. Rao et al., Diagn. Mol. Pathol. 2, 264 (1993); G. Kovacs, K. Tory, A. Kovacs, J. Pathol. 173, 39 (1994).
28. D. Rau et al., Hum. Genet. 89, 64 (1992); S. Hunter, T. Gramlich, K. Abbott, V. Varma. Genes Chromosomes Cancer 8, 172 (1993); A. A. Sandberg, J. Cell Biochem. Suppl. 161, 76 (1992); J. J. Konig et al., Prostate 25, 281 (1994); P. H. Rao et al., Diagn. Mol. Pathol. 2, 264 (1993); G. Kovacs, K. Tory, A. Kovacs, J. Pathol. 173, 39 (1994).
29. D. Rau et al., Hum. Genet. 89, 64 (1992); S. Hunter, T. Gramlich, K. Abbott, V. Varma. Genes Chromosomes Cancer 8, 172 (1993); A. A. Sandberg, J. Cell Biochem. Suppl. 161, 76 (1992); J. J. Konig et al., Prostate 25, 281 (1994); P. H. Rao et al., Diagn. Mol. Pathol. 2, 264 (1993); G. Kovacs, K. Tory, A. Kovacs, J. Pathol. 173, 39 (1994).
30. P. J. Carder et al., Br. J. Cancer71, 215 (1995).
31. -9. Thus, the model suggests that the collision hypothesis cannot account for the observed data.
32. For mixed (XO/XY) adenomas, mean width = 5.93 crypts (n = 13); and for all adenomas, mean width = 6.82 (n = 285) and SEM = 0.554. The width of mixed adenomas does not differ significantly from that of the general polyp population (normal distribution, two-tailed test, P > 0.1).
33. H. F. Willard, K. D. Smith, J. Sutherland, Nucleic Acids Res. 11, 2017 (1983).
34. We thank P. Sasieni for assistance with the statistical analysis and A. Rowan for performing the protein truncation test.